DASATINIB 70 mg (Leu Kinib) x 60 Tablets

Uses of DASATINIB

• Used for Philadelphia chromosome-positive chronic myeloid leukemia
• Used for newly diagnosed chronic phase CML
• Used for CML when previous treatment is not effective or not tolerated
• Used for Philadelphia chromosome-positive acute lymphoblastic leukemia
• Helps control abnormal white blood cell growth
• Used as part of targeted leukemia treatment

Benefits of DASATINIB 70 mg

• Helps slow leukemia cell growth
• Targets BCR-ABL related cancer signals
• Supports long-term disease control in suitable patients
• Provides an oral treatment option
• May help patients who do not respond well to imatinib
• Helps reduce abnormal blood cell multiplication
• Supports personalised blood cancer treatment
• May improve treatment response when taken regularly

How Does DASATINIB Work?

Dasatinib works by blocking abnormal tyrosine kinase proteins, especially BCR-ABL, which drive the growth of Philadelphia chromosome-positive leukemia cells. By blocking these signals, Dasatinib helps slow or control the multiplication of abnormal blood cells.

Side Effects

• Diarrhea
• Headache
• Nausea
• Tiredness or weakness
• Skin rash
• Muscle pain
• Shortness of breath
• Loss of appetite
• Low white blood cell count
• Low platelet count
• Low red blood cell count
• Bleeding or bruising
• Fluid retention or swelling
• Pleural effusion, rarely
• Heart or lung problems, rarely

Precautions

• Take only as prescribed by your doctor.
• Tell your doctor if you have heart disease, lung disease, liver problems, bleeding problems, or low blood counts.
• Regular blood tests may be needed during treatment.
• Report fever, breathing trouble, unusual bleeding, swelling, chest pain, or severe weakness.
• Avoid pregnancy and breastfeeding during treatment.
• Inform your doctor about all medicines and supplements you take.
• Do not stop or change the dose without medical advice.